Sleep Apnoea Linked to Considerably Higher risk of Parkinson’s Disease, Research Reveals
Table of Contents
A common sleep condition which affects millions of Britons is linked to a significantly higher risk of developing Parkinson’s disease, new research has revealed.
In a study published in teh Journal of the American Medical Association (JAMA), scientists found that people with sleep apnoea, a condition which causes breathing problems when you sleep, were nearly twice as likely to develop Parkinson’s disease as those who didn’t.
But researchers said that early treatment of the disorder could slash the risk of developing the disease,which affects a person’s movement with tremors,muscle stiffness and slow movement,with 28,000 Britons diagnosed each year.
Scientists said that effective screening measures and consistent use of CPAP (continuous positive airway pressure) machines, which are worn as a mask to deliver continuous air through the mouth or nose to help prevent drops in oxygen, could have “large impacts on the brain”.
Those who used a CPAP machine within 2 years of a sleep apnoea diagnosis were nearly 30 per cent less likely to develop Parkinson’s disease.
Parkinson’s diagnosis Times Remain “Painfully Slow” Due to NHS Backlog
London, UK – November 30, 2025 – Thousands of people in the UK are facing lengthy delays in receiving a diagnosis for Parkinson’s disease, with some waiting over five years to see a neurologist, according to Parkinson’s UK. The charity attributes these delays to a “painfully slow” recovery of neurology services following the disruption caused by the COVID-19 pandemic and a pre-existing NHS backlog. These delays leave individuals in a state of uncertainty and fearing the worst while awaiting crucial medical assessment.
Impact of NHS Backlogs on Parkinson’s Diagnosis
the COVID-19 pandemic significantly exacerbated existing pressures on the National Health Service (NHS),leading to a ample backlog in non-emergency care,including neurology appointments. This backlog continues to impact the timely diagnosis of neurological conditions like Parkinson’s disease. Parkinson’s UK warns that the situation is leaving many individuals in limbo, unable to access the support and treatment they need.
Caroline Rassell, Chief Executive of Parkinson’s UK, stated, “The painfully long Covid backlog, and slow recovery of neurology services, has left thousands of people with Parkinson’s struggling to be seen. Some people are waiting five years to see a neurologist. All too frequently enough we hear they are bounced between services, in a state of uncertainty, fearing the worst whilst they wait for a diagnosis.”
Understanding parkinson’s Disease
Parkinson’s disease is a progressive neurological disorder that affects movement.Symptoms typically develop slowly and can vary significantly from person to person. Common symptoms include:
* Tremor
* Rigidity
* Slowed movement (bradykinesia)
* Postural instability
* Balance problems
Early diagnosis is crucial for managing the condition effectively and accessing appropriate treatments and support. While there is currently no cure for Parkinson’s, treatments can definately help manage symptoms and improve quality of life.
Calls for Urgent Action
Parkinson’s UK is urging the NHS to prioritize the recovery of neurology services and reduce waiting times for diagnosis. The charity emphasizes the importance of investing in neurology staffing and resources to meet the growing demand for care. They also advocate for improved pathways for patients to navigate the diagnostic process, reducing the instances of being “bounced between services.”
The charity expects diagnosis numbers to rise as the backlog is addressed and more people are able to access neurological assessments. Though, they stress that proactive measures are needed to prevent further delays and ensure that individuals with Parkinson’s receive timely and appropriate care.
Key Takeaways
* NHS backlogs,worsened by the COVID-19 pandemic,are causing important delays in Parkinson’s disease diagnosis.
* Some individuals are waiting over five years to see a neurologist.
* Parkinson’s UK is calling for urgent action to prioritize neurology services and reduce waiting times.
* Early diagnosis is crucial for effective management of Parkinson’s disease.
Looking Ahead: Addressing the NHS backlog and investing in neurology services are critical steps towards ensuring that individuals with Parkinson’s disease receive the timely diagnosis and care they deserve. Continued advocacy from organizations like Parkinson’s UK will be essential in driving positive change and improving the lives of those affected by this condition.
Related reading